Nearly every day, there are new reports of antibiotic resistance bacteria – superbugs – that are becoming more difficult to treat. Early this year, the Centers for Disease Control and Prevention reported on the death of a woman in Nevada who had a resistant bacterial infection that was impervious to 26 different antibiotic drugs.
bioMérieux – First-Quarter 2017 Business Review
Marcy l'Étoile (France), April 20, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2017.
bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system
Marcy l’Étoile (France) - April 6, 2017 – bioMérieux, a major player in the field of in vitro diagnostics, and the world leader in microbiology, announces that BacT/ALERT® VIRTUO™, its fully automated blood culture system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Spring Holiday Shipping Schedule 2017
Please be advised that bioMérieux Inc. sites in Durham, St. Louis, Louisville and Lombard will be closed on Friday, April 14 in observance of the upcoming holiday.
bioMérieux Opens New Production Line at Durham Facility, Expanding Capacity of BacT/ALERT® Blood Culturing Bottles Vital in Fight Against Resistant Infections
Durham, NC – March 29, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce the opening of a new production line at its Americas Headquarters in Durham, North Carolina.
bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis
bioMérieux, a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of VIDAS® B•R•A•H•M•S PCT™, an automated assay measuring procalcitonin (PCT) levels, to help clinicians make important decisions regarding the optimal use of antibiotics in two common clinical situations: lower respiratory tract infections (LRTI) and sepsis.
bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury
bioMérieux, a world leader in the field of in vitro diagnostics and Banyan Biomarkers, an innovative biomarkers company developing blood tests capable of diagnosing traumatic brain injuries (TBI), announced today that they have entered into a partnership.
bioMérieux – Fourth-Quarter 2016 Business Review
Marcy l'Étoile, January 19, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the twelve months ended December 31, 2016.
Year End Holiday Shipping Schedule
Please be advised that bioMérieux sites in Durham, St. Louis, Louisville and Lombard will be closed on Thursday, November 24 and Friday, November 25 as well as Monday, December 26 and Tuesday, December 27 in observance of the upcoming holidays.
Veteran's Day Shipping Schedule
As part of our commitment to providing you more efficient and better services we will be upgrading our ERP system, SAP, on Friday, November 11, 2016.